MEA / Mourad Ishak – General Manager MEA Region, Farmak
Mourad Ishak began heading up Farmak’s MEA region as general manager in 2021, after almost two decades in the industry. He explains the Ukranian complex generics maker’s decision to set…
Address: 63 Frunze St., Kyiv, Ukraine
Tel: +38 044496-89-63
Web: http://farmak.ua/en/
The Open Joint Stock Company Farmak is one of the oldest pharmaceutical companies in Ukraine, manufacturing finished medicines and pharmaceutical substances. The company was established in 1991 on the basis of Kiev’s M. V. Lomonosov Chemical-Pharmaceutical Plant, which began producing synthetic medicines in 1925. Over the 80 years of its existence the company has become one of the leading manufacturers in the local pharmaceutical industry.
endocrinology, ophthalmology, otolaringology, X-ray contrast media, ophthalmology, otolaringology, X-ray contrast media
Mourad Ishak began heading up Farmak’s MEA region as general manager in 2021, after almost two decades in the industry. He explains the Ukranian complex generics maker’s decision to set…
In 1996, Jiří Žák, chairman & current CEO of FARMAK, took over the state-owned producer of vitamins FARMAKON where he previously worked for 30 years and turned it into a…
Filya Zhebrovska, chairman of the supervisory board of Farmak and the company’s general director between 1995 and 2017, provides insights into the strategy she has followed to establish Farmak as…
Igor Bondarenko of Ukraine’s Dnipro State Medical University, Evgeny Levenko from clinical trials company, ARENSIA, and Olena Popova from IQVIA offer their perspectives on maintaining quality and ensuring participant protection…
The March edition of DIA’s Global Forum magazine features a special section on clinical research in Ukraine, over one year on from the beginning of the Russian invasion. Here, Chieko…
The March edition of DIA’s Global Forum magazine features a special section on clinical research in Ukraine, over one year on from the beginning of the Russian invasion. Anina Adelfio…
Russia’s invasion of Ukraine has been roundly condemned by the pharmaceutical industry and almost all Big Pharmas have pledged humanitarian support to Ukraine. However, not all companies have followed the…
Ukraine’s bold decision to outsource public procurement of medicines to international agencies to combat rampant corruption has been well received by the pharma MNCs operational in the country, but faces…
Vladimir Sayenko, founding partner, and Anzhela Makhinova, counsel, of the leading Ukrainian law firm Sayenko Kharenko, give an overview on the Ukrainian pharmaceutical industry in 2017 and explain the expansion…
Tetiana Korotchenko, Country Representative of Crown Agents, one of the three international organizations contracted by the Ukrainian government to temporarily handle healthcare procurement and put an end to the plague…
Dmytro Popov, the owner, founder and CEO Elfa Group, Ukraine’s leading cosmetics manufacturer, provides his insight into Elfa’s 20-year presence in the Ukrainian market, the company’s international growth strategies and…
Dr. Maxim Sokolov, chief external specialist of the Ministry of Health of Ukraine in cardiology, principal scientist of the Department of Interventional Cardiology of the National Academy of Medical Sciences…
Dr. Paul Melekhov, vice president Eastern Europe at Pharmascience, Canada’s third largest generic company, provides insights into the unique history of Pharmascience in Ukraine and the pioneering market approach that…
Julia Sidorova, country manager of Alvogen, a new international player to the Ukrainian market, provides insights into the targeted strategy that Alvogen employs throughout the world and how this is…
Victoria Filatova, president and chairperson of the Association of Perfumery and Cosmetics of Ukraine (APCU), discusses her strategic priorities, the association’s main achievements in its six years of existence, and…
See our Cookie Privacy Policy Here
